Patent eligibility in the US is trending upward with two recent Federal Circuit decisions
The Supreme Court’s recent decision not to hear the Sequenom Inc v Ariosa Diagnostics Inc case disappointed many observers in the US who had been hoping that the justices would use it as means to clarify current uncertainties around Section 101 of…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.